Thanks, House. I'm also wondering if they are re
Post# of 148831
(Total Views: 415)
Posted On: 12/18/2024 8:03:48 AM
Re: HouseofCards #148774
Thanks, House. I'm also wondering if they are required or allowed to PR such news in the middle of the trial. Since it's an open-label trial, I wouldn't see why not.
The protocol has been published at clinicaltrials.gov. I noticed that they did not exclude patients with the Delta 32 mutation (single or double allele). I wonder if this is a mistake -- ? Would be happy to if anyone with a better understanding of Leron's MOA eased my mind.
The protocol has been published at clinicaltrials.gov. I noticed that they did not exclude patients with the Delta 32 mutation (single or double allele). I wonder if this is a mistake -- ? Would be happy to if anyone with a better understanding of Leron's MOA eased my mind.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼